Clinical Evaluation of Cardiac Resynchronization Therapy (CRT) Using the Ovatio CRT Implantable Cardioverter-defibrillator (ICD) System
Clinical Evaluation of Cardiac Resynchronization Therapy With Implantable Cardioverter-defibrillator Therapy
This study provides a continued access registry for cardiac resynchronization therapy with defibrillation (CRT-D), which helps to resynchronize (coordinate) the rhythm of the heart by helping the left ventricle contract (pump blood) more uniformly, in patients with severe heart failure (New York Heart Association [NYHA] Class III or IV).
Quality of life, adverse events and device success will be analyzed and reported.
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Descrizione dettagliata
ICDs have been shown to increase life expectancy substantially over various drug regimens in patients with life threatening ventricular arrhythmias. Furthermore, large scale studies of cardiac resynchronization therapy in ICD-indicated heart failure patients have demonstrated improvements in functional capacity and quality of life, without unacceptable increases in morbidity or mortality.
This study provides a continued access registry for cardiac resynchronization therapy with defibrillation (CRT-D), which helps to resynchronize (coordinate) the rhythm of the heart by helping the left ventricle contract (pump blood) more uniformly, in patients with severe heart failure (NYHA Class III or IV).
Quality of life, adverse events and device success will be analyzed and reported.
Tipo di studio
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- Accepted indication for ICD implant
- Severe heart failure (NYHA Class III or IV) at the time of enrollment
- May have pre-existing ICD, provided subject is on stable, optimal medical regime
- Sinus rhythm with spontaneous QRS duration greater than or equal to 150 ms, or a QRS duration greater than or equal to 130 ms with an inter-ventricular mechanical delay (IVMD) greater than or equal to 40 ms
- Left-ventricular ejection fraction (LVEF) of 35% or less
Exclusion Criteria:
- Any generally accepted indication for standard cardiac pacing, or any contraindication for standard cardiac pacing
- Any contraindication for ICD therapy
- Currently implanted with a lead positioned in or through the coronary sinus
- Hypertrophic or obstructive cardiomyopathy
- Acute myocarditis
- Unstable coronary symptoms (unstable angina or myocardial infarction) within the last month
- Recent or planned cardiac revascularization or coronary angioplasty
- Correctable valvular disease that is the primary cause of heart failure
- Mechanical tricuspid valve
- Chronic atrial arrhythmia or cardioversion for atrial fibrillation within the past month, or paroxysmal atrial fibrillation requiring new pharmacologic therapy within the past month
- Systolic blood pressure consistently above 170 mmHg or consistently below 80 mmHg
- Supine resting heart rate exceeding 100 bpm
- Receiving continuous IV infusion of positive inotropic therapy or intermittent therapy (IV infusion) more than twice per week
- Heart transplant recipient
- Primary pulmonary disease of a severity that might limit the patient's ability to perform a treadmill test
- Serum creatinine above 3.0 mg/dL
- Serum hepatic functions at or above three times the upper normal limit
- Cerebrovascular event within the previous three months
- Inability to walk or other physical impediments which might prevent the patient from completing a maximum, symptom-limited treadmill test
- Age of less than 18 years
- Pregnancy
Piano di studio
Come è strutturato lo studio?
Collaboratori e investigatori
Sponsor
Studiare le date dei record
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Stima)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Stima)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- ITAC06
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su Ovatio CRT
-
Children's Hospital of PhiladelphiaThe Hilda & Preston Davis FoundationCompletato
-
Guy's and St Thomas' NHS Foundation TrustKing's College LondonNon ancora reclutamento
-
University Hospital OlomoucNon ancora reclutamento
-
Universidad Complutense de MadridCompletato
-
Inova Health Care ServicesMedtronicAttivo, non reclutanteBlocco di branca sinistro | Insufficienza cardiaca (HF) | Frazione di eiezione ventricolare sinistraStati Uniti
-
Medtronic Cardiac Rhythm and Heart FailureCompletatoMalattie cardiache | Blocco atrioventricolareStati Uniti, Canada
-
Montreal Heart InstituteCanadian Institutes of Health Research (CIHR); Abbott Medical DevicesTerminatoArresto cardiacoCanada
-
Medtronic Cardiac Rhythm and Heart FailureTerminatoInsufficienza cardiaca congestizia | Insufficienza cardiaca sistolica | Blocco di branca sinistroStati Uniti, Svezia, India, Federazione Russa, Regno Unito
-
University of RochesterNational Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...ReclutamentoArresto cardiaco | Terapia di risincronizzazione cardiaca | Blocco di branca destro | Stimolazione del suo pacchettoStati Uniti
-
University of Sao Paulo General HospitalFundação de Amparo à Pesquisa do Estado de São Paulo; Conselho Nacional de Desenvolvimento...Completato